The Aesthetic Guide is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Sitemap


Articles from 2022 In September


Aesthetic MVPs: Noury Adel, MSc: Trailblazing the Aesthetic Industry

Article-Aesthetic MVPs: Noury Adel, MSc: Trailblazing the Aesthetic Industry

Aesthetic MVPs: Noury Adel, MSc: Trailblazing the Aesthetic Industry

To help catapult the next generation of thought leaders into the next stage of their careers, Informa Markets Aesthetics (IM- Aesthetics; im-aesthetics.com) has created the Medical Aesthetic Vanguard Program (MVP). Intended for pioneering aesthetic specialists in practice ten years or less, who are on track to make significant contributions to the field of aesthetic medicine, this program provides all the tools necessary to increase exposure and foster priceless connections within the medical aesthetic industry.

There is a limited capacity, so to bNine years ago, oral and maxillofacial surgeon, Noury Adel, MSc, transitioned to focus on nonsurgical, anti-aging treatments using facial injectables and threads and has never looked backecome an “MVP” you must be invited or nominated by a colleague within the medical aesthetic industry. Those accepted as MVPs are given opportunities to strengthen their education, build status and legitimacy as a key opinion leader (KOL) and/or subject matter expert (SME), and receive national recognition, including this feature profile in this new section we are calling “Aesthetic MVPs”.

To kick off this new column, we interviewed an exemplary MVP, Noury Adel, MSc, an oral and maxillofacial surgeon who has been focusing on nonsurgical aesthetics for almost nine years.

In addition to creating the 3-Point Lips technique, Dr. Adel is one of the top aesthetic injectors in Egypt. Furthermore, he is a well-recognized speaker and trainer for many programs, conferences and webinars.

Dr. Adel is currently an official certified trainer for SoftFil Cannula and i-THREAD. He has trained plastic surgeons, dermatologists and dentists on facial aesthetics. He earned a master’s degree in oral and maxillofacial surgery in 2019 and is also known for his scientific research published in local and international journals.

TAG: Dr. Adel, can you tell us a little bit about why you chose to become a medical professional?

Since I was a student in school, I have had a great passion for biology and human anatomy. I was always fascinated by how the human body works and interacts. That is why I always knew that one day I wanted to be a doctor.

TAG: How and why did you choose your specific specialty?

To be honest, I never thought of being a facial aesthetic practitioner. I always wanted to be a surgeon, which I eventually accomplished when I got my master’s degree in oral and maxillofacial surgery after I finished dental school. Still, I had to work on tumors, jaw fractures, reconstruction surgery, etc.

MVP Icebreakers Noury Adel, MScAnd, I loved doing it and helping patients, but there was always something missing inside. When I took a training program on facial aesthetics and learned about the tremendous results that can be achieved with nonsurgical aesthetic interventions (fillers and neuromodulators), I laid down my blade. I felt that this is my calling. I call it the spark! This is what I was meant to do.

TAG: What is your primary area of interest within aesthetic medicine?

Nonsurgical, anti-aging treatments using facial injectables and threads.

TAG: Are you currently working on any clinical research studies related to your area of interest? Or any that you have recently finished?

Yes, I am currently working on new research. I recently had two of my research studies published in the PRS global open journal, one about my signature technique of doing lip filler injections using microcannulas – the 3-Point Lips. And the other is about my approach to treating gummy smile patients using a standardized injection technique and dosage protocol.

TAG: What challenges do you think your generation or the next generation of aesthetic practitioners will face?

There is an increase in the number of aesthetic practitioners. I think this is good for our patients because they come to us with different desires and need practitioners with various skills to fulfill these needs. But these questions remain: Is everyone qualified? Does everyone seek evidence-based medicine, or are they learning from Instagram videos? Do we uphold the integrity of natural treatments or hastily adopt trends like Russian lips or fox eyes? Do we educate our patients about what is wrong and what is right?

My only concern is the lack of control or regulations on the practice of aesthetic medicine, combined with the increase in the number of aesthetic practitioners, may negatively impact the primary goal of facial aesthetics. The good news is that we have an abundance of talented and ethical individuals that maintain the balance in this industry.

TAG: When it comes to your professional journey, where do you see yourself in five years?

I see myself as a KOL, I would also love to have my own educational and academic institution to train and teach a new generation of clinicians. I want to build a legacy.

TAG: You were invited to present as an MVP at The Aesthetic Show this year. What did that mean to you?

It is one of the top conferences of all time, many brilliant minds gather to share knowledge. What could be better than this?

Updates in Microneedling

Article-Updates in Microneedling

Updates in MICRONEEDLING

Stemming from the use of hypodermic needles to treat wrinkles and scars, in 1997, Des Fernandes, MBBCh, developed the first stamping device to induce collagen production. Today the treatment is known as microneedling, and even though it suffered a setback during the Covid-19 pandemic with restrictions on elective aesthetic procedures, it is making a strong return.

According to a report published in Transparency Market Research, microneedling is forecasted to grow at a compound annual growth rate (CAGR) of 7.9% to reach a market value of $1.1 billion by 2031, thanks to a rise in demand for cosmetic treatments, along with developments in technology.1

Physiology of Microneedling

microneedling article headshotsControlled micro-injuries caused by microneedling initiate a wound healing cascade resulting in an increased production of connective tissue growth factors while leaving the epidermis undamaged. A fibronectin matrix forms approximately five days after treatment, leaving the skin tighter and more youthful. One retrospective analysis found that skin treated with four sessions one month apart increased collagen and elastin deposition up to 400%.2

As well as being a popular treatment for collagen induction therapy, microneedling enhances the delivery of topicals by creating micro-channels in the skin that allow for deeper penetration into the dermis, making this treatment a staple in many cosmetic practices and medspas. Despite these advancements and benefits, microneedling continues to boast a low cost of entry for aesthetic practices, physicians, patients and clients.

Trends in Microneedling Treatment Protocols

Facial plastic surgeon Steven Weiner, MD, laid down his scalpel in 2005 and now focuses on non-invasive cosmetic treatments at The Aesthetic Clinique in Santa Rosa microneedling headshots 2Beach, Fla. In Dr. Weiner’s opinion, radiofrequency (RF) microneedling provides a superior treatment compared to standard microneedling. “RF microneedling gives much better results for tightening and acne scars than microneedling,” he shared. “The RF causes coagulation leading to greater collagen and elastin production.”

According to Suneel Chilukuri, MD, director of cosmetic surgery at Refresh Dermatology (Houston, Texas), RF microneedling technology can also be used to treat acne. “RF microneedling is a great option for early intervention for scarring while the resolution of acne is occurring. It is extremely safe, and you can use it on all skin types,” he said. “We use it on patients with active acne, including pustular and cystic acne, and see a tremendous reduction in the size of the sebaceous glands. By decreasing the size of the sebaceous gland with an external device producing heat, there is less oil production, so it is a very cost-effective mechanism for decreasing acne,” he added.

Christine Petti, MD, a plastic surgeon from Torrance, Calif., uses innovative treatments for nonsurgical skin tightening and is also a fan of RF microneedling. “One of my favorite RF microneedling protocols is to aggressively treat smile and marionette lines, jawline, submental laxity and necmicroneedling headshots 3klace lines. For these problem areas I try to stack the depth and maintain the RF level and time (milliseconds). By stacking, I mean varying the depth from 2.5 mm to 3.0 mm to 3.2 mm to create a ‘column’ of dermal injury and thereby an inflammatory response that will result in a pillar of collagenesis to support and thicken the skin in the treated areas. The results I have seen in my patients are a smoothing and filling in of these smile lines, such that it appears that they had dermal filler treatments,” she emphasized.

Varying treatment depth has allowed J.D. McCoy, ND, founder of Contour Medical (Gilbert, Ariz.), to treat his patients more aggressively with improved comfort. “Historically, I would only be able to treat about 1 mm or deeper,” he said. “I use a device that allows me to treat very superficially on the first pass to target pigment in the superficial facial membrane for collagen stimulation and to desensitize the skin. After superficially treating the patient’s skin, I go back and do a deeper pass with much more comfort.”

Dr. McCoy is able to also treat the neck and jowl, historically a challenge for non-invasive cosmetic treatments. “There has been an evolution in the technology and RF microneedling is a necessity for me, at least for the neck and jowl,” he reported. “The key is going deep enough to target the fibro-septal network and deliver enough energy for effemicroneedling headshot 4ctive tissue coagulation. I have seen the most coagulation and the most shrinkage from using the Sylfirm X, a dual-wave RF microneedling device from BENEV (Mission Viejo, Calif.), with a non-insulated needle for clean energy delivery. I often do one side first and show my patients the difference, because the results are impressive,” he explained.

Plastic and reconstructive surgeon Erez Dayan, MD, medical director at Avance Plastic Surgery Institute (Reno, Nev.), called attention to studies that are currently looking at protocols comparing different microneedling and outcomes. At least one study showed that RF microneedling is an effective tool for physicians to achieve tissue retraction compared to energy-based devices alone.3 “It will be interesting to see how the histologic outcomes compare in terms of collagen remodeling and regeneration,” Dr. Dayan indicated.

Combination and Specialized Treatments

Dr. Chilukuri combines RF microneedling with other treatments for his signature neck lift. “Wemicroneelding headshot 5 first use RF microneedling followed by the 1927 thulium laser to get results similar to surgery.” Along with the neck lift, Dr. Chilukuri has great success with treating smile lines around the eyes using a treatment he calls a C-Lift. “We do two or three treatment sessions spaced about four to six weeks apart using the Sylfirm X for significant results. When the patient smiles, the eye lines do not crinkle because this method thickens the dermis.”

Dr. DayBefore and three months after three RF microneedling treatments Photo courtesy of Steven Weiner, MDan mainly uses microneedling to improve surgical and traumatic scars, and in combination with platelet-rich plasma (PRP) for facial rejuvenation. “We have seen faster recovery and improved results with microneedling and PRP,” he shared. “But one of my favorite combination treatments is microneedling with medium depth chemical peels (35% TCA with Jessner’s solution). This is a powerful yet safe anti-aging treatment to correct fine lines and wrinkles of the face and neck.”

According to Dr. McCoy, combining microneedling with certain injectables can provide comfort with enhanced results. “I do combination therapy using bio-stimulant filler to volumize and stimulate collagen from the inside out and microneedling to treat skin from the outside in,” he shared. “I do this in a single appointment because products like Sculptra (Galderma) or Bellafill (Suneva) have numbing agents in them, so I will inject those first to get a good numbBefore and after treatment with RF microneedling Photos courtesy of Christine Petti, MDing of the area to make microneedling more comfortable and then do the microneedling over the top in the same visit.”

Additionally, Dr. McCoy uses dual wave RF microneedling to treat difficult melasma and pigment issues that could historically only be treated with laser. “Ethnic skin types are also difficult to treat with laser as safety becomes a concern. However, patients that might not be good candidates for laser-based treatment typically are good candidates for RF microneedling. This is a breakthrough as darker skin types typically do not have as many options on the laser-based side, but with the microneedling we can treat all skin types.”

Updated Microneedling Technologies

The Secret PROTM from Cutera® (Before and three months after one treatment with Sylfirm X from BENEV Photos courtesy of J.D. McCoy, NDBrisbane, Calif.) is an innovative and versatile device that can treat skin texture, pore size and stimulate collagen production for all skin types. With a fractional CO2 laser for skin resurfacing, along with RF microneedling to initiate hemostasis and coagulation for deep dermal remodeling, the Secret PRO delivers exceptional results and a superior experience. “There is little downtime associated with the RF microneedling on the Secret PRO, so many patients use this as a ‘weekend treatment,’” explained Michael Somenek, MD, a facial plastic surgeon in Washington, D.C. “As someone who has used many RF microneedling devices, this has one of the best ergonomic handpieces, making it easy to use, and patients are comfortable with how the device delivers the microneedles. The user can adjust the settings, including the depth and more importantly, the RF time, which can really maximize results.”

H. William Song, MD, of Omni Aesthetics MedSpa (Santa Monica, Calif.) prefers the Rejuvapen NXT® by Refine USA (Jacksonville Beach, Fla.). “The powerful motor and ergonomic design make this device stand out from similar devices on tBefore and after treatment with Secret PRO from Cutera Photos courtesy of Michael Somenek, MDhe market,” he expressed. “We recommend regular microneedling with Rejuvapen NXT to every patient in our practice because it is safe, and it works.” The Rejuvapen NXT is an FDA-cleared microneedling device that treats facial wrinkles as it provides flexibility to customize treatments for optimal results. The innovative design features plug-in power for consistent speed and patented disposable tips to improve procedure safety while eliminating suction and clogging during treatment. The device has been clinically proven to deliver safe, effective and reliable results for patients of all skin types and aging severity.

Agnes RF from Agnes (Torrance, Calif.) incorporates RF energy for tissue coagulation and electrothermolysis, with micro-insulated needles to penetrate the skin at specific points while distributing RF energy at precise temperatures to generate a tissue response without damaging the epidermis. Jack Zamora, MD, a facial plastic surgeon based in Denver, Colo., uses the Agnes RF as the foundation for his non-invasive facial sculpting. “Agnes allows us to deliver powerful levels of RF energy to coagulate subdermal tissue in the safest way possible,” he said. “We use other RF microneedling devices for more superficial treatments; however, for deep yet non-invasive treatments, nothing delivers a visible arc plasma effect in the subdermal space like Agnes.”

According to Dr. Zamora, the larger insulated needles can deliver visible and palpable skin contraction outcomes. He also uses it to enhance some surgical procedures, including difficult-to-treat jowls.

SkinPen by Crown Aesthetics (Dallas, Texas) is the ideal gateway technology to help physicians grow their practice. It delivers dramatic rejuvenation results in a quick, comfortable and affordable procedure that patients love. As the first FDA-cleared microneedling device, SkinPen Precision is now cleared to improve the appearance of neck wrinkles and facial acne scars. Engineered and manufactured in the U.S., with over 90 validation studies ensuring quality, safety and performance, SkinPen Precision sets a standard in microneedling.

“We have used the SkinPen Precision device for several years and keep getting positive feedback from our patients,” said board-certified plastic surgeon Gregory Buford, MD (Lone Tree, Colo.). “It provides optimal outcomes with less tissue damage than some of its competitors so downtime is minimized while results are optimized. We also see less drag with it than with other devices which equates to less collateral tissue damage and downtime.”

Clinicians at Esthetic Medical (Scottsdale, Ariz.) have created SkinStylus® Sterlock, an affordable FDA-cleared microneedling system built by practitioners for practitioners.

This device features a revolutionary patented SteriStamp® and SteriTip®, non-absorbent sterile applicator for PRP and microneedling.

Gretchen Frieling, MD, dermatologist and CEO of G Face MD in Wellesley, Mass., explained how SkinStylus works. “The small microneedles penetrate the skin at varying depths to stimulate collagen formation gently and gradually,” she advised. “Patients with acne scarring and post-inflammatory hyperpigmentation can achieve significant softening and correction of the scars and pigment.” The SkinStylus can be used both cordless and corded and offers three different cartridge options including a revolutionary 36 pin HiLo cartridge offering three times the treatment efficiency of other systems.

With prejuvenation in mind, dermatologist Tonya McLeod, MD (Charlotte, N.C.), combines her microneedling treatments with PRX Derm Perfection from Love Beauty Pro & Medical (Woburn, Mass.). This innovative regenerative clinical aesthetic treatment combines the effects of hydrogen peroxide, 33% TCA and kojic acid.

“I use this as an anti-aging defense for prejuvenation and a rejuvenating skin tightening treatment. I also incorporate PRX to treat stretch marks, skin laxity on the face, upper arms and legs, especially after significant weight loss or aging,” Dr. McLeod reported. “With PRX, I can offer options for spring and summer treatments and increased possibilities for cosmetic treatments in skin type IV-V.” PRX is a no-downtime, no-photosensitivity treatment that is safe for all skin types and targets aging skin, texture, laxity, wrinkles and dull skin for complete rejuvenation of the face and body.

Adjunctive Topicals

EMC Pharma (Maryland Heights, Mo.) focuses on innovative and cost-effective medications and incorporates their exclusive hypochlorous acid (HOCI) into their products. Michael Gold, MD, founder of Gold Skin Care Center (Nashville, Tenn.) uScar before and after treatment with SkinStylus Sterlock from Esthetic Medical Photos courtesy of Samer Muala, MDses the company’s Lasercyn and Celacyn Scar Gel with HOCI to eradicate bacteria, reduce inflammation and pruritus, break down biofilm and increase oxygenation.

“Lasercyn is one of the most stable hypochlorous acid products on the market and one of the go-to technologies for prepping the skin before all of the procedures we do, whether RF microneedling, microneedling, or any laser or injectable procedure. HOCl kills virtually everything on contact and is safe to use anywhere and on anyone,” Dr. Gold reported. “Celacyn uses a specialized drug delivery along with silicones to improve scars, and studies have demonstrated its effectiveness. When using this product during a procedure, I am assuring that my patient will not have any major potential inflammatory pathogens – before, during or after. There is nothing else on the market that does this,” he added.

Topicals for post-microneedling Before and after six treatments with SkinPen from Crown Aesthetics Photos courtesy of Cathy A. Presnickcan significantly improve patient outcomes, as demonstrated by AnteAGE MD® Brightening Solution from AnteAGE (Irvine, Calif.). This topical adjunct can be safely applied to the skin after microneedling to treat stubborn pigmentation and stop new discoloration from forming by blocking all seven pathways to melanogenesis. According to Alexis Stephens, MD, at Parkland Dermatology, AnteAGE MD Brightening Solution can help take patients’ microneedling results to the next level. “It improves results of treatment for discoloration and dramatically cuts down on the number of sessions needed by allowing patients to achieve an even skin tone much faster. Incorporating this solution also improved the clinic workflow by allowing me to use just one serum per session.”

Recovery dramatically affects the patient experience, and take-home treatments can help improve results. The Epionce Essential Recovery Kit® is an all-in-one take-home kit for post-procedure barrier repair. It is clinically proven to reduce erythema and transepidermal water loss (TEWL) post-treatment and to reduce 95.5% of Malassezia yeast in 30 seconds. Carl Thornfeldt, MD, founder and CEO of Epionce in Boise, Idaho, uses microneedling combined with superficial chemical peels, RF or LED for anti-aging to reverse photodamage in the skin and for acne. He explained the importance of managing the patient’s healing with the all-in-one approach of the Epionce kit. “The Epionce Essential Recovery Kit provides all of the key functions for proper healing: semioBefore and after microneedling treatment Photos courtesy of Gretchen Frieling, MDcclusion, hydration, accelerating epidermal and barrier repair and preventing microbial infection, and it is the only post-procedure kit documented to statistically improve signs of photo-aging four weeks after the procedure compared to standard acetic acid soaks and a lanolin-based ointment regimen.”

Protocols for Improved Results and Complication Avoidance

In Dr. McCoy’s practice, awareness of the patient environment is part of preparation, while pre- and post-procedure therapies are an important aspect of patient comfort and outcomes. “I try to be mindful of the patient’s environment, including their hydration status and electrolyte balance,” he explained. “I am in the middle of Arizona, so most patients are dehydrated. Ensuring they are sufficiently hydrated can greatly improve the results and comfort during treatment,” he explained. While Dr. McCoy is careful to screen his patients; he takes advantage of the numbing effects of certain injectables as part of his pre-procedure treatment; and he also applies topical exosomes post-procedure to help speed healing.

As with any medical treatment, microneedling can have its complications. According to Dr. Weiner, complications from microneedling are rare; however, an area over-treated with too many passes may develop post-inflammatory hyperpigmeBefore and after three treatments with microneedling + PRX-T33 Derm Perfexion from Love Beauty Pro & Medical Photos courtesy of Catelyn Hollowayntation (PIH). He also warns that prolonged swelling or redness can occur. Patients can have reactions to topicals applied immediately after treatment because some are not meant to penetrate deeply into the skin, which may lead to granuloma and infections.

Dr. Weiner explained that specific pre- and post-treatment protocols can help avoid complications. “I use sterile gloves, I clean the skin with alcohol and Hipiclens prior to treatment, and then again post-procedure with gauze soaked with hypochlorous acid,” he shared. “I use ultrasound to measure skin thickness prior to all RF microneedling treatments. This allows for exact placement of the needles to the deepest part of the dermis (the area of maximum collagen and elastin creation) and avoids going into the subcutaneous fat, which can lead to fat loss in rare cases. I do not go shallower than 1.5 mm in skin types IV-VI.”

Emerging Treatment Protocols

Owing to these and other piThe Epionce Essential Recovery Kit is an all-in-one take-home kit for post-procedure barrier repaironeering practitioners looking for ways to create a nonsurgical facelift, microneedling has evolved past the stage of only treating fine lines. “I am aware that industry research is working to develop techniques that will enable physicians to deliver special pharmacological agents into the dermis with microneedling to effect even more rapid and dramatic collagenesis,” Dr. Petti inferred. “Also, stem cell infusion into the dermis shows promise for achieving the fountain of youth effect, where the dermis is replenished with young cells that can maintain the youthful appearance of the skin.”

Innovative technology is sparking a revolution in microneedling, and progressing interest in nonsurgical therapies, creating a bright future not only for this technology and treatment, but the world of aesthetics as a whole.

References:
1. Microneedling Market (Technique: Manual and Automated; Product: Dermapen, Dermaroller, RF Microneedling Devices, and Others; Material: Silicon, Titanium, Stainless Steel, Polymers, and Others; Application: Skin Rejuvenation, Scarring, Acne, Wrinkles, and Others; and End-user: Hospitals, Dermatology Clinics, Homecare Settings, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
2. .Litchman G, Nair PA, Badri T, et al. Microneedling. [Updated 2022 May 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https:// www.ncbi.nlm.nih.gov/books/NBK459344/
3. Dayan E, Chia C, Burns AJ, Theodorou S. Adjustable Depth Fractional Radiofrequency Combined with Bipolar Radiofrequency: A Minimally Invasive Combination Treatment for Skin Laxity. Aesthet Surg J. 2019 Apr 8;39(Suppl_3):S112-S119. doi: 10.1093

 

Women in Aesthetics

Women in Aesthetics: Jennifer Levine, MD: Finding the Art in Medicine

Article-Women in Aesthetics: Jennifer Levine, MD: Finding the Art in Medicine

Women in Aesthetics: Jennifer Levine, MD: Finding the Art in Medicine

As a child, Jennifer Levine, MD, wanted to be president of the United States. Sadly, her dream was quickly shot down when she was told that it was impossible because she was female. “I remember being really upset about the realization that being a girl would prevent me from becoming President; and sadly, we have yet to see a woman as President,” Dr. Levine emphasized. Although she was disheartened, she pivoted her childhood dream and decided that she wanted to be the future editor of Vogue MagaziDr. Levine hiking in Tucson, AZne. But as luck would have it, fate had other plans, leading Dr. Levine on the path to medicine, where she is now a world-renowned, award-winning, double board-certified facial plastic surgeon.

Despite being told that women had no place in male-dominated industries in her youth, Dr. Levine went to medical school. “I skipped two years of school and graduated high school before I was 16. I went to college, medical school, then residency,” she explained.

When starting her residency at Lenox Hill in 1995, she was the only woman amongst 20 men. “I was not prepared since my medical school was roughly 50:50. I had come from an academic environment where there was a semblance of equality. I soon learned that female equality in surgery was nonexistent. I did not have the fortune of having female mentors, and the women in surgery had the attitude that if they suffered, then so should I,” she recalled.

After successfully getting through her residency, Dr. Levine made herself a promise, “When I started my practice, I vowed to make sure that I would take a different approach and offer a helping hand to any woman in medicine who needed it. I am proud to say thatDr. Levine (left) in Mykonos with her daughters Kate (middle) and Payton (right) 15 years later, I run an all-women practice,” she enthused.

An Innate Appreciation of Art & Beauty

From an early age, Dr. Levine had a profound appreciation for the intersection of beauty, precision and mathematics. Her interest in the arts and sciences helped pave the way for her career in aesthetic medicine. “I was always interested in art, particularly drawing and sketching of faces,” she shared.

To put herself through medical school, Dr. Levine worked as a calligrapher. “I studied calligraphy for many years; who says all doctors have bad handwriting,” she joked.

“As I went through school, I was drawn, pun intended, to the exactness and problem-solving of math and science. For me, being a doctor and practicing medicine is the perfect combination of both art and science,” she shared.

“I also studied fa Finding the Art in Medicineshion illustration, animation and cartooning. The lines and movement of the human form was a passion of mine, so aesthetic plastic surgery was a natural field for me. And, I also love innovation and technology. I have always thought of myself as an innovator, and I like to think out of the box. The aesthetic field is one that is always changing and growing, so I really enjoy it,” Dr. Levine elaborated.

Preservation, Persistence & Presence

The path to becoming the fellowship-trained facial plastic surgeon and beauty expert she is today did not come without its challenges. During Dr. Levine’s residency, they tried to close the hospital where her residency was based and disband her program. “In an instant, I realized that all my hard work and long hours of studying could ultimately be for nothing. I decided then that I would never put my faith in an institution again and that I would work for myself,” she stated.

Shortly after the residency program almost dissolved, Dr. Levine became pregnant. “I knew I wanted to have a career, and I knew I wanted to be a mother. My balance of these two, sometimes opposing, goals has shaped my choices,” she explained. “I was planning on applying to fellowship programs, but I knew I would not be able to travel. Some of my attending physicians were in the process of creating a fellowship in facial plastic surgery, so I spoke to my chairman. I got the fellowship approved for the year following my final year of residency. This fellowship is still in existence today.”

Juggling a professional life with motherhood is no small feat. What helps Dr. Levine strike a balance, is presence. “Like any mom, I do the best I can. The world wants women to work like they do not have children and parent like they do not work outside the home. I try to be present no matter where I am or who I am with. When I am a mom, I try not to think about work. At work, I focus on my job. Being present is important,” she acknowledged.

Now, Dr. Levine has two daughters, Payton 22, and Kate 16.

“Fun fact, the daughter I was pregnant with during residency, Payton, just graduated from my alma mater, Columbia University, following in my footsteps,” she exclaimed.

Dr. Levine’s inspiring personal and professional journey continues to evolve. She has been in practice on the Upper East Side of Manhattan for 18 years, “It is where I trained, and I never left,” she added. She is in a private solo practice where she likes to combine surgical and nonsurgical procedures, and she is working on opening a second office with an operating room – a feat very few female surgeons have achieved.

In the coming years, she intends to continue growing and transforming her career and the industry as a whole, “I see myself with offices in multiple locations, traveling and lecturing internationally and having a product line. I want to advance equity in the field and look forward to having women in the surgical fields be fairly represented on the podium, in the media, and in research and publications.”

Facial Plastic Surgeons Donate Time to Repair Facial Injuries for Ukrainian Refugees & Soldiers

Article-Facial Plastic Surgeons Donate Time to Repair Facial Injuries for Ukrainian Refugees & Soldiers

Facial Plastic Surgeons Donate Time to Repair Facial Injuries for Ukrainian Refugees & Soldiers

WHO: The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), the world’s largest association of facial plastic surgeons. FACE TO FACE is a humanitarian and educational surgical exchange program sponsored by the Educational and Research Foundation for the (AAFPRS). 


WHAT: An interdisciplinary medical team of 16 including six AAFPRS facial plastic and reconstructive surgeon members will soon travel to the Ukraine on a medical mission to assist those with facial injuries suffered because of the Russia/Ukraine conflict.

The AAFPRS, with its extensive network of board certified facial plastic and reconstructive surgeons, is working to partner with local organizations in Ukraine and adjacent countries to share members’ expertise in the management of complex facial injuries and to send facial plastic surgeons into a safe environment where care can be provided to those who are injured and in need of reconstructive and urgent facial surgery services. The AAFPRS will also treat injured Ukrainian refugees, providing pro bono care through its network of FACE TO FACE members.

FACE TO FACE is coordinating with various organizations including Razom, and Dr. Ivanka Nebor, founder of InGenius, as well as individuals on the ground in Ukraine, to get a better understanding of how AAFPRS members can safely and productively assist with local partners.  
    
This trip was initiated by AAFPRS member and facial plastic surgeon John Frodel, MD. "When I started watching the horrors that were happening in Ukraine at the end of February, I couldn't help but think that this was going to be very bad, as it involved over 100,000 invading Russian troops. It became obvious that there were going to be many soldiers and civilians involved with potentially devastating injuries. It seemed to be a time for FACE TO FACE to offer some assistance.”

FACE TO FACE Committee Chair Manoj Abraham, MD immediately assembled a group of AAFPRS physicians with experience in organizing and conducting medical trips around the world. Dr. Abraham has extensive experience in this area and has been instrumental in orchestrating medical trips to Colombia, Peru, Ethiopia, India and multiple other international sites. AAFPRS President, Dr. Corey Maas, MD, among others, will also make the trip.

 

WHEN: The nine day mission is scheduled for mid-September to two hospitals. 

 

INTERVIEWS: For more information or to connect with an AAFPRS spokesperson, please contact - Pattymathews@kelzmedia.com.

 

ABOUT THE AAFPRS:
The American Academy of Facial Plastic and Reconstructive Surgery is the world’s largest specialty association for facial plastic surgery. It represents more than 2,200 facial plastic and reconstructive surgeons throughout the world. The AAFPRS is a National Medical Specialty Society of the American Medical Association (AMA), and holds an official seat in both the AMA House of Delegates and the American College of Surgeons board of governors. AAFPRS members are board certified surgeons whose focus is surgery of the face, head, and neck (inclusive of Rhinoplasty and Facial Rejuvenation). More information at [www.aafprs.org]www.aafprs.org.

 

ABOUT FACE TO FACE:
Founded in 1992, FACE TO FACE is a humanitarian and educational surgical exchange program sponsored by the Educational and Research Foundation for the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). Both in the United States and abroad, AAFPRS surgeons and other medical professionals provide complimentary care to those who suffer from facial deformities caused by birth or trauma. To date, it is estimated that FACE TO FACE volunteers have helped over one thousand people worldwide.

 

Source:

AAFPRS

Revance Announces FDA Approval of DAXXIFY for Injection, the First and Only Peptide-Formulated Neuromodulator With Long-Lasting Results

Article-Revance Announces FDA Approval of DAXXIFY for Injection, the First and Only Peptide-Formulated Neuromodulator With Long-Lasting Results

Revance logo

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved DAXXIFY™ (DaxibotulinumtoxinA-lanm) for injection for the temporary improvement of moderate to severe frown lines (glabellar lines) in adults.1 DAXXIFY™ is the first and only neuromodulator stabilized with Peptide Exchange Technology™ (PXT) and is free of both human serum albumin and animal-based components.1-2,7-11 Most importantly, DAXXIFY™ has the ability to address duration of treatment effect, which we believe is the greatest unmet need with existing neuromodulators for both consumers and injectors.12 The FDA approval, Revance’s first, augments the company’s innovative aesthetics portfolio and expands the company’s access to the growing $3.2 billion U.S. facial injectables market, further establishing Revance as an innovation leader in the industry and laying the groundwork for potential future therapeutic indications.13

“The FDA approval of DAXXIFY™ is a foundational achievement for the company as it marks the culmination of years of pioneering research and development made possible by the outstanding execution of our talented team, along with strong support from the medical and investor communities. It has been an incredible and rewarding journey to realize our vision and bring this disruptive innovation to an industry that has remained largely unchanged for over 30 years,” said Mark J. Foley, Chief Executive Officer. “Importantly, we are very pleased DAXXIFY™’s label includes data demonstrating the achievement of none or mild wrinkle severity based on investigator and subject assessments, as this provides the foundation for our marketing claims around duration of effect. We look forward to continuing to set new standards in aesthetics and to establishing a new category of long-lasting, peptide-enhanced neuromodulators.1,11

Jeffrey Dover, MD, co-director of SkinCare Physicians of Chestnut Hill, commented, “As a SAKURA investigator, I’m pleased to see DAXXIFY™ now approved as the first and only peptide-formulated, long-acting neuromodulator in the market. Compelling data from the largest Phase 3 clinical program ever conducted for glabellar lines demonstrated that DAXXIFY™ was well tolerated and achieved clinically significant improvement with long-lasting results and high patient satisfaction. Notably, DAXXIFY™ was able to demonstrate a long duration of effect while only utilizing 0.18 ng of core active ingredient in the 40-unit labeled indication for glabellar lines. With today’s approval, I look forward to helping patients, who have been accustomed to a 3 to 4-month duration profile with conventional neuromodulators, achieve year-long results with as few as two treatments per year.2-5 *

The U.S. approval of DAXXIFY™ was based on the data generated in the SAKURA Phase 3 clinical trial program (SAKURA 1,2,3), which included more than 2,700 patients and approximately 4,200 treatments. In the pivotal trials:

74% of subjects achieved a > two-grade improvement in glabellar lines at week 4 per both investigator and patient assessment1,4¶
88% achieved > two-grade improvement at week 4 per investigator assessment1¶
98% of subjects achieved none or mild wrinkle severity at week 4 per investigator assessment 4¶
6-month median duration3,4*
Some patients maintained treatment results at 9 months2-4‡
Results seen as early as one day after treatment, typically seen within two days14¶
DAXXIFY™ is generally safe and well tolerated with no serious treatment-related adverse events reported in the clinical trials and has a safety profile consistent with other currently available neuromodulators in the aesthetics market.1-5,7-10 The most common treatment-related adverse events with DAXXIFY™ observed in the pivotal trials were headache (6%) followed by eyelid ptosis (2%) and facial paresis, including facial asymmetry (1%).1

“With DAXXIFY’s innovative and differentiated performance profile, alongside our portfolio that includes the RHA® Collection of dermal fillers and the OPUL® Relational Commerce platform, we have a real opportunity to build on our commercial success while setting a new standard for neuromodulator formulation,” said Dustin S. Sjuts, President. “The strong inroads that we have made in the prestige market with our products and services will serve as a solid foundation upon which to launch DAXXIFY™. Consistent with our commercial strategy, DAXXIFY™ will be available through Revance Aesthetics’ elite partners, known for delivering exceptional consumer outcomes and experiences. We are excited to be launching DAXXIFY™ shortly with an early training and education program at our world-class headquarters and experience center in Nashville, followed by a broader commercial launch.”

Practices interested in receiving more information on DAXXIFY™ may reserve their spot at RevanceAesthetics.com.

 

Read more here.

 

Source:

Business Wire

Revision Skincare Announces Strategic Partnership with RVL Pharmaceuticals, Inc.

Article-Revision Skincare Announces Strategic Partnership with RVL Pharmaceuticals, Inc.

Revision Skincare

Revision Skincare®, a leading medical-grade professional skincare brand, announced today a partnership with RVL Pharmaceuticals, Inc. the owner of UPNEEQ®, the first and only FDA-approved prescription eye drop for the treatment of acquired ptosis (low-lying lids) in adults.

This strategic partnership pairs two unique disruptors within the aesthetics and skincare industries, both focused on providing patients with high-quality results. With shared values and visions for business growth and an expanding footprint, the collaboration aligns two game-changing brands to offer more accessible solutions to aesthetic patients and providers nationwide.

For more than two decades, Revision Skincare has been at the forefront of physician-dispensed brands. From pioneering the use of peptides to developing proprietary technologies and conducting novel ingredient research, this professional skincare brand creates clinically validated, high-potency products that protect, treat, and enhance the skin.

As another company invested in optimal patient health, RVL Pharmaceuticals offers appropriate patients a nonsurgical solution for acquired ptosis and provides results in as fast as 5 minutes with UPNEEQ.

"We know that RVL Pharmaceuticals has a lot of choices when it comes to commercial partnerships. We are excited to join this mission with RVL to offer breakthrough patient solutions," said Maria Carell, CEO, and President, Revision Skincare.

Through the partnership, Revision Skincare and RVL Pharmaceuticals will bring broader access to revolutionary innovations like D·E·J Eye Cream®, Revox™ Line Relaxer, and UPNEEQ. The two companies plan to collaborate on a variety of marketing efforts within the medical aesthetics industry, working together to address significant unmet consumer needs.

"We are thrilled to partner with Revision Skincare! Their strong history of innovation and passion for skin health aligns with our core directive around ocular medical aesthetics," said Brian Markison, CEO, RVL Pharmaceuticals.

Revision Skincare and RVL Pharmaceuticals have an unwavering commitment to innovation as consumers, patients, and health care partners look to them to provide solutions to their patients' medical aesthetic needs. For more information, contact your local aesthetic skincare professional's office.

About Revision Skincare
Revision Skincare is an industry leader in developing clinically-validated, high potency, transformative skincare products. Our unique formulation philosophy is an integrated approach that delivers maximum efficacy while maintaining long-term skin health. Based in Irving, Texas, Revision Skincare is sold in more than 16 countries.

About RVL Pharmaceuticals
RVL Pharmaceuticals is a specialty pharmaceutical company focused on the commercialization of UPNEEQ (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelids, in adults. UPNEEQ is believed to be the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.

IMPORTANT SAFETY INFORMATION INDICATION
UPNEEQ (oxymetazoline hydrochloride ophthalmic solution), 0.1% is indicated for the treatment of acquired blepharoptosis in adults.

WARNINGS AND PRECAUTIONS

Ptosis may be associated with neurologic or orbital diseases such as stroke and/or cerebral aneurysm, Horner syndrome, myasthenia gravis, external ophthalmoplegia, orbital infection and orbital masses. Consideration should be given to these conditions in the presence of ptosis with decreased levator muscle function and/or other neurologic signs.

Alpha-adrenergic agonists as a class may impact blood pressure. Advise UPNEEQ patients with cardiovascular disease, orthostatic hypotension, and/or uncontrolled hypertension or hypotension to seek medical care if their condition worsens.

Use UPNEEQ with caution in patients with cerebral or coronary insufficiency or Sjögren's syndrome. Advise patients to seek medical care if signs and symptoms of potentiation of vascular insufficiency develop.

UPNEEQ may increase the risk of angle closure glaucoma in patients with untreated narrow-angle glaucoma. Advise patients to seek immediate medical care if signs and symptoms of acute narrow-angle glaucoma develop.

Patients should not touch the tip of the single patient-use container to their eye or to any surface, in order to avoid eye injury or contamination of the solution.

ADVERSE REACTIONS
Adverse reactions that occurred in 1-5% of subjects treated with UPNEEQ were punctate keratitis, conjunctival hyperemia, dry eye, blurred vision, instillation site pain, eye irritation and headache.

DRUG INTERACTIONS
Alpha-adrenergicagonists, as a class, may impact blood pressure. Caution in using drugs such as betablockers, anti-hypertensives, and/or cardiac glycosides is advised. Caution should also be exercised in patients receiving alpha adrenergic receptor antagonists such as in the treatment of cardiovascular disease, or benign prostatic hypertrophy.

Caution is advised in patients taking monoamine oxidase inhibitors which can affect the metabolism and uptake of circulating amines.

 

Read more here.

 

Sources: 

Revision Skincare / PR Newswire